Wellington Management Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-560,565
Closed -$667K 2171
2022
Q3
$667K Buy
560,565
+93,913
+20% +$146K ﹤0.01% 1724
2022
Q2
$840K Hold
466,652
﹤0.01% 1707
2022
Q1
$942K Buy
466,652
+32,669
+8% +$64.2K ﹤0.01% 1746
2021
Q4
$1.18M Buy
+433,983
New +$1.6M ﹤0.01% 1776
2020
Q1
Sell
-29,812
Closed -$311K 2098
2019
Q4
$311K Sell
29,812
-18,670
-39% -$136K ﹤0.01% 1938
2019
Q3
$190K Sell
48,482
-15,736
-25% -$127K ﹤0.01% 1996
2019
Q2
$955K Buy
64,218
+46,123
+255% +$833K ﹤0.01% 1780
2019
Q1
$449K Buy
+18,095
New +$454K ﹤0.01% 1915
2018
Q4
Sell
-18,215
Closed -$535K 2247
2018
Q3
$535K Buy
+18,215
New +$705K ﹤0.01% 2022
2018
Q2
Sell
-29,911
Closed -$1.58M 2345
2018
Q1
$1.58M Buy
+29,911
New +$1.75M ﹤0.01% 1801
2017
Q2
Sell
-1,331,669
Closed -$84.8M 2328
2017
Q1
$84.8M Buy
1,331,669
+1,318,669
+10,144% +$80.2M 0.02% 568
2016
Q4
$577K Sell
13,000
-178,122
-93% -$6.27M ﹤0.01% 1980
2016
Q3
$6.89M Buy
+191,122
New +$4.1M ﹤0.01% 1289

Other funds holding CLVS

Wellington Management Group's CLVS Position: Q4 2022 in Review

Wellington Management Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 560,565 shares — an estimated $667K sold.

Wellington Management Group first reported a position in CLVS in Q3 2016 and held it in 13 quarters. The position peaked at $84.8M in Q1 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Wellington Management Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 560,565 Clovis Oncology, Inc. shares in Q4 2022, an estimated $667K.
  • Wellington Management Group first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 13 quarters.
  • Wellington Management Group's Clovis Oncology, Inc. position peaked at $84.8M in Q1 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.